Filter by: patients
What is Kapidex?

Kapidex is a brand name for dexlansoprazole, a delayed release capsule for the once-daily, oral treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
GERD (Gastroesophageal reflux disease) 12 2 Efficacy_moderate
Acid reflux 6 3 Efficacy_major Efficacy_cant_tell
hyper-acidity 4 0
Gastric Ulcer 1 0
Barrett's Esophagus 1 1 Efficacy_slight

See all 20 patients currently taking Kapidex

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
1
None
5

Reported Dosages

  1 cap(s) daily 1 mg daily 20 mg daily 30 mg daily 40 mg daily 60 mg daily 90 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 12 Number of Patients: 12 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Kapidex (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2   Doctor's advice: 50%
Other 1   Other: 25%
Change in health plan coverage 1   Change in health plan coverage: 25%

See all 4 patients who’ve stopped taking Kapidex

Currently Taking Kapidex

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Kapidex

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Kapidex

Always
6 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Kapidex

Very
0 0%
Somewhat
0 0%
A little
1 17%
Not at all
5 83%

Cost

Paid out of pocket

Cost of Kapidex

$200+
0 0%
$100-199
1 33%
$50-99
0 0%
$25-49
0 0%
< $25
2 67%

Report created on May 27, 2012.